Abstract
This study has examined the efficacy following intramuscular administration of a recombinant Semliki Forest virus (rSFV) vaccine, encoding the prME and NS1 proteins of louping ill virus (LIV), in sheep. Administration of rSFV-LIV vaccine resulted in transient detection at the injection site and draining lymph node only and no dissemination to distal sites. In addition, the recombinant vaccine offered complete protection against subcutaneous challenge with LIV, and partial protection following intranasal administration of LIV. Protected animals had no pathological changes normally associated with LIV infection, and had developed high antibody titres. In contrast, the two animals not protected exhibited classical clinical signs and neuropathological lesions of LIV infection. These findings indicate that rSFV-based vaccines have the potential to be developed as effective prototype vaccines for LIV.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies, Viral / blood
-
Base Sequence
-
DNA Primers / genetics
-
Encephalitis Viruses, Tick-Borne / genetics*
-
Encephalitis Viruses, Tick-Borne / immunology*
-
Encephalitis, Tick-Borne / immunology
-
Encephalitis, Tick-Borne / pathology
-
Encephalitis, Tick-Borne / prevention & control
-
Encephalitis, Tick-Borne / veterinary
-
Genetic Vectors
-
Reverse Transcriptase Polymerase Chain Reaction
-
Semliki forest virus / genetics*
-
Semliki forest virus / immunology*
-
Sheep
-
Sheep Diseases / immunology
-
Sheep Diseases / pathology
-
Sheep Diseases / prevention & control
-
Vaccines, Synthetic / genetics
-
Vaccines, Synthetic / immunology
-
Vaccines, Synthetic / pharmacology
-
Viral Nonstructural Proteins / genetics*
-
Viral Nonstructural Proteins / immunology*
-
Viral Structural Proteins / genetics*
-
Viral Structural Proteins / immunology*
-
Viral Vaccines / genetics
-
Viral Vaccines / immunology
-
Viral Vaccines / pharmacology
Substances
-
Antibodies, Viral
-
DNA Primers
-
Vaccines, Synthetic
-
Viral Nonstructural Proteins
-
Viral Structural Proteins
-
Viral Vaccines